Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Targeting inflammation with collagen

D. Schwarz, M. Lipoldová, H. Reinecke, Y. Sohrabi

. 2022 ; 12 (5) : e831. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018533

Tissue damage caused by an infection oran autoimmune disease triggers degradation of collagen in the extracellular matrix (ECM), which further enhances inflammation. Therefore, improving ECM in aninflamed tissue can be exploited as a potential therapeutic target. A recentstudy emphasised an innovative approach against COVID-19 using polymerised type I collagen (PTIC) that improves disease severity through a hitherto unknownmechanism. In this paper, we provide an overview of potential mechanism thatmay explain the anti-inflammatory effect of collagen peptides. In addition,the paper includes a brief summary of possible side effect of collagendeposition in inflammatory diseases. Altogether, current knowledge suggeststhat collagen may potentially reduce the residual risk in inflammatorydiseases; however, the detailed mechanism remains elusive.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018533
003      
CZ-PrNML
005      
20220804134835.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ctm2.831 $2 doi
035    __
$a (PubMed)35604877
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Schwarz, Dennis $u Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Münster, Münster, Germany
245    10
$a Targeting inflammation with collagen / $c D. Schwarz, M. Lipoldová, H. Reinecke, Y. Sohrabi
520    9_
$a Tissue damage caused by an infection oran autoimmune disease triggers degradation of collagen in the extracellular matrix (ECM), which further enhances inflammation. Therefore, improving ECM in aninflamed tissue can be exploited as a potential therapeutic target. A recentstudy emphasised an innovative approach against COVID-19 using polymerised type I collagen (PTIC) that improves disease severity through a hitherto unknownmechanism. In this paper, we provide an overview of potential mechanism thatmay explain the anti-inflammatory effect of collagen peptides. In addition,the paper includes a brief summary of possible side effect of collagendeposition in inflammatory diseases. Altogether, current knowledge suggeststhat collagen may potentially reduce the residual risk in inflammatorydiseases; however, the detailed mechanism remains elusive.
650    12
$a COVID-19 $7 D000086382
650    _2
$a kolagen $x metabolismus $x farmakologie $7 D003094
650    _2
$a kolagen typu I $x metabolismus $x farmakologie $7 D024042
650    _2
$a extracelulární matrix $x metabolismus $7 D005109
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x farmakoterapie $x metabolismus $7 D007249
650    _2
$a farmakoterapie COVID-19 $7 D000093485
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lipoldová, Marie $u Laboratory of Signal Transduction, Institutes of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Reinecke, Holger $u Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Münster, Münster, Germany
700    1_
$a Sohrabi, Yahya $u Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Münster, Münster, Germany $u Laboratory of Signal Transduction, Institutes of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia $1 https://orcid.org/000000015268238X
773    0_
$w MED00193505 $t Clinical and translational medicine $x 2001-1326 $g Roč. 12, č. 5 (2022), s. e831
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35604877 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134829 $b ABA008
999    __
$a ok $b bmc $g 1822228 $s 1169776
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 5 $d e831 $e - $i 2001-1326 $m Clinical and translational medicine $n Clin Transl Med $x MED00193505
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace